Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 2:24 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1345–1368 of 3,253 matching trials from the live ClinicalTrials.gov search.

Filters: Not yet recruiting Clear all

Conditions: MASH - Metabolic Dysfunction-Associated Steatohepatitis, MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease), Fibrosis and Cirrhosis of Liver, MetALD
Interventions: Not listed
Lead sponsor: Active Genomes Expressed Diagnostics, Corp; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Stress
Interventions: Placebo Relaxation Control, Active Relaxation Product 1; Dietary Supplement
Lead sponsor: Radicle Science; Industry
Eligibility: 21 Years to 105 Years
Enrollment: 550 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Del Mar, California

Conditions: Down Syndrome, Intellectual Disability, Alzheimer Dementia (AD)
Interventions: Memantine; Drug
Lead sponsor: University Hospitals Cleveland Medical Center; Other
Eligibility: 18 Years to 32 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Advanced Cutaneous Melanoma, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Cutaneous Melanoma
Interventions: Biospecimen Collection, Internet-Based Intervention, Medical Device Usage and Evaluation, Phototherapy, Questionnaire Administration, Therapeutic Tumor Infiltrating Lymphocytes; Procedure · Other · Biological
Lead sponsor: City of Hope Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Duarte, California

Conditions: Pelvic Organ Prolapse (POP), Postoperative Pain, Urogynecology
Interventions: Suzetrigine, Placebo; Drug
Lead sponsor: Aditi Talkad; Other
Eligibility: 40 Years to 80 Years · Female only
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Severe Traumatic Brain Injury
Interventions: Not listed
Lead sponsor: Corewell Health West; Other
Eligibility: 18 Years to 65 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Grand Rapids, Michigan

Conditions: Lumbar Disc Herniation Surgery, Disc Herniation
Interventions: Postoperative therapy; Other
Lead sponsor: Intrinsic Therapeutics; Industry
Eligibility: Not listed
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Shreveport, Louisiana

Conditions: Sarcopenia, Frailty
Interventions: BandPass System; Device
Lead sponsor: SynchroHealth LLC; Industry
Eligibility: 65 Years and older
Enrollment: 39 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 2
States / cities: Chapel Hill, North Carolina

Conditions: Hepatocellular Carcinoma, Pancreas Cancer, Biliary Tract Neoplasms
Interventions: Actigraphy, Online Mindfulness Meditation, Smartphone Application-based Intervention, Survey Administration; Other · Behavioral
Lead sponsor: City of Hope Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027
U.S. locations: 1
States / cities: Duarte, California

Conditions: Epilepsy, Drug Resistant
Interventions: Sham Mediodorsal Thalamic (MD) Deep Brain Stimulation + Centromedian Thalamic (CM) Deep Brain Stimulation, Low-Frequency Mediodorsal Thalamic Deep Brain Stimulation, High-Frequency Mediodorsal Thalamic Deep Brain Stimulation, Mediodorsal Thalamic Deep Brain Stimulation using optimal settings; Device
Lead sponsor: Gregory Worrell; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Prostate Cancer
Interventions: Pasritamig; Drug
Lead sponsor: Fred Hutchinson Cancer Center; Other
Eligibility: 18 Years and older · Male only
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Soft Tissue Sarcoma (STS)
Interventions: 5-ALA; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Overactive Bladder, Overactive Bladder Syndrome, Urinary Urgency, Urinary Frequency, Urge Incontinence, Neurogenic Bladder
Interventions: Lidocaine 2% without vessel constrictor; Drug
Lead sponsor: University of Louisville; Other
Eligibility: 18 Years and older · Female only
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Chronic Kidney Disease
Interventions: Nicotinamide Riboside (NR), Matched Placebo (Capsules); Dietary Supplement
Lead sponsor: University of California, San Diego; Other
Eligibility: 30 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: San Diego, California

Conditions: Shoulder Arthroplasty, Total Shoulder Arthroplasty
Interventions: Mirror Anatomic Total Shoulder Prosthesis, Medacta Anatomic Shoulder; Device
Lead sponsor: Medacta USA; Industry
Eligibility: 22 Years and older
Enrollment: 286 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 12
States / cities: Gilbert, Arizona • Boca Raton, Florida • Gulf Breeze, Florida + 9 more

Conditions: Wellness, Self Compassion, Burnout, Anxiety, Depression
Interventions: App-based bundled mental fitness intervention, App-based wellness module collection; Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Drug Toxicity
Interventions: Not listed
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: Not listed
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Neurosurgery, Surgical Planning, Brain Tumor Adult, Craniotomy Tumor Removal Surgery
Interventions: Mixed Reality Glasses/Viewer, Survey using a questionnaire.; Device · Other
Lead sponsor: Brainlab AG; Industry
Eligibility: 18 Years and older
Enrollment: 54 participants
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Cardiac Surgery, Blood Transfusion, Anemia, Cardiopulmonary Bypass
Interventions: Demand-Informed Transfusion Decision Rule; Other
Lead sponsor: Yan Mia Min; Other
Eligibility: 18 Years and older
Enrollment: 900 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Postural Malalignment, Forward Head Posture, Rounded Shoulder Posture
Interventions: Virtual reality exercise, Active free Exercise; Other
Lead sponsor: Hofstra University; Other
Eligibility: 18 Years to 35 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Hempstead, New York

Conditions: Hypoactive Sexual Desire Disorder
Interventions: Oral Testosterone Undecanoate; Drug
Lead sponsor: San Diego Sexual Medicine; Other
Eligibility: 21 Years to 75 Years · Female only
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: San Diego, California

Conditions: Plagiocephaly, Brachycephaly, Asymmetric Head
Interventions: MyCRO Band, Traditional CRO; Device
Lead sponsor: Otto Bock HealthCare LP; Industry
Eligibility: Not listed
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Madison Heights, Michigan

Conditions: Breast Imaging, Breast Cancer
Interventions: 2-D Monochromatic X-ray Mammography System; Device
Lead sponsor: Imagine Scientific, Inc.; Industry
Eligibility: 40 Years and older · Female only
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Cannabis Use, Substance Use Disorder (SUD), Healthy
Interventions: Placebo Oral Capsule, THC; Drug
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years to 21 Years
Enrollment: 144 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027 – 2031
U.S. locations: 1
States / cities: Chicago, Illinois

Search by objective public record fields.

AGED Diagnostics Clinical Validation Study

Radicle Relaxation™ CIX: A Study Assessing the Impact of Health and Wellness Products on Stress and Related Health Outcomes

Escalating Doses of Memantine in Down Syndrome (MEDS-123)

Circadian-Optimized Light Therapy for the Treatment of Patients With Advanced Melanoma Receiving Tumor-Infiltrating Lymphocyte Therapy

Suzetrigine Following Urogynecologic Surgery: Investigation of Postoperative Pain Management

The Systemic Nature of Severe Traumatic Brain Injury

Return to Activity After Surgery for Lumbar Disc Herniation

BandPass: A Remote Monitoring System for Sarcopenia and Functional Decline Phase II Aim 4

Scheduled Meditation for Improving Postoperative Outcomes in Patients Undergoing Pancreatectomy

RESTORE: Restoring State-dependent Thalamocortical Oscillations in Epilepsy

Testing Pasritamig Before Surgery for the Treatment of Localized Prostate Cancer

5-AminoLevulinic Acid Aided Resection Margins in Sarcoma

Optimal Intravesical Lidocaine Volume for Pain Relief During Office Intra-detrusor Onabotulinum Toxin a Injections

Nicotinamide Riboside Supplementation in Chronic Kidney Disease

A Trial to Assess the Safety and Effectiveness of an Anatomic Total Shoulder System

A Study of a Mental Fitness Intervention for Anesthesiology Resident Wellbeing and Self-Compassion

Real World Asparaginase Therapy Toxicity

Real Time Craniotomy Planning Using Mixed Reality

Personalized Blood Transfusion Protocol for Cardiac Patients

Virtual Reality Versus Traditional Exercise on EMG Activity in Postural Malalignment

An Open-Label Study of 50 Mg Oral Testosterone Undecanoate (Kyztrex) in Menopausal Women with Low Testosterone and HSDD

Cranial Remolding Orthosis Registry

Study of Monochromatic X-ray Mammography System

Research Investigating Drug Effects-2 (RiDE-2)